Enhancing the interpretation of diabetes-related risk in ALD-ACLF: a methodological perspective

Yiran Xie^{1

2}, Xi Guo^{1

2}, Junyu Xi^{1

2}, Weijing Liu^{3

4

5}

Affiliations

¹ Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.
² Key Laboratory of Chinese Internal Medicine of Ministry of Education, Beijing Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.
³ Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China. liuweijing-1977@hotmail.com.
⁴ Key Laboratory of Chinese Internal Medicine of Ministry of Education, Beijing Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China. liuweijing-1977@hotmail.com.
⁵ Renal Research Institution of Beijing University of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100700, China. liuweijing-1977@hotmail.com.

Yiran Xie et al. Hepatol Int. 2025.

. 2025 Dec 17.

doi: 10.1007/s12072-025-10988-z. Online ahead of print.

Yiran Xie^{1

2}, Xi Guo^{1

2}, Junyu Xi^{1

2}, Weijing Liu^{3

4

5}

¹ Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.
² Key Laboratory of Chinese Internal Medicine of Ministry of Education, Beijing Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.
³ Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China. liuweijing-1977@hotmail.com.
⁴ Key Laboratory of Chinese Internal Medicine of Ministry of Education, Beijing Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China. liuweijing-1977@hotmail.com.
⁵ Renal Research Institution of Beijing University of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100700, China. liuweijing-1977@hotmail.com.

No abstract available

Conflict of interest statement

Declarations. Conflict of interest: The authors declare that they have no interests that could have influenced the work reported in this paper.

1. Kumar A, Arora A, Sharma P, Maiwall R, Choudhury A, Arora V, et al. Diabetes mellitus is linked to higher mortality in alcohol-related acute-on-chronic liver failure. Hepatol Int. 2025. https://doi.org/10.1007/s12072-025-10914-3 - DOI - PubMed
1. Tang ASP, Tan C, Lim WH, Ng CH, Tan DJH, Zeng R, et al. Impact of pretransplant diabetes on outcomes after liver transplantation: an updated meta-analysis with systematic review. Transplantation. 2024;108:1157–1165. https://doi.org/10.1097/tp.0000000000004840 - DOI - PubMed
1. Hong AT, Lin F, Luu IY, Shin L, Han SM, Armstrong DG, et al. Risk of lower extremity complications with GLP-1 receptor agonists, SGLT2 inhibitors, and DPP-4 inhibitors in peripheral artery disease. Diabetes Res Clin Pract. 2025;230: 112982. https://doi.org/10.1016/j.diabres.2025.112982 - DOI - PubMed - PMC
1. Apte M, Zambre S, Pisar P, Roy B, Tupe R. Decoding the role of aldosterone in glycation-induced diabetic complications. Biochem Biophys Res Commun. 2024;721: 150107. https://doi.org/10.1016/j.bbrc.2024.150107 - DOI - PubMed
1. Shang Y, Grip ET, Modica A, Skröder H, Ström O, Ntanios F, et al. Metabolic syndrome traits increase the risk of major adverse liver outcomes in type 2 diabetes. Diabetes Care. 2024;47:978–985. https://doi.org/10.2337/dc23-1937 - DOI - PubMed - PMC